Industry
Pharmaceuticals
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Pharmaceuticals
... a new drug. APH (TSX), $6.94 down 84¢ or 10.8% over week CONCORDIA INTERNATIONAL Test your business knowledge! Shares of Concordia International plummeted after the ...
... 29 Sep 28 Central Asia Met 6.5p (5.50) Oct 06 Oct 05 Consort Medical 13.21p (12.56) Sep 22 Sep 21 Dart Group 3.897p (3.10) Sep ...
... 20, 2017) - The following issues have been halted by IIROC: Concordia International Corp. TSX Symbol: CXR (all issues) Pending News Halt Time (ET) IIROC ...
... Toronto, Ontario--(Newsfile Corp. - October 20, 2017) - Trading resumes in: Concordia International Corp. TSX Symbol: CXR (all issues) Resumption Time (ET): IIROC can make ...
... president of commercial business at Anthem Blue Cross, in a statement. INDICATIONS Celgene stock tumbles after late stage drug failure. Biotech giant Celgene faced an ...
... a pound of flesh from critics rarely ends well for companies. Count Concordia International as the latest example. The company’s former chief executive, Mark Thompson, ...
... Merck & Co. said Friday it is laying off about 1,800 U.S. sales representatives, ...
... Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has ...
... Medivir AB (Nasdaq Stockholm: MVIR)announces that data from the initial phase IIa study ...
... 2.5.1. Growth Drivers: 2.5. Growth Drivers and Resistors for Biologics 2.4.3. Risankizumab; AbbVie/Boehringer Ingelheim 2.4.2. Cimzia (certolizumab pegol; UCB/Dermira Pharmaceuticals) 2.4.1. Tildrakizumab; Merck / Sun ...
... Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic)today announces in vivo data from compounds ...
... Concordia is seeking to reduce its existing secured and unsecured debt obligations by ...
... Technology (OGT) - Pacific Biomarkers - Proteome Sciences - Caprion Proteomics - WuXi PharmaTec - ICON plc - Charles River Laboratories - Parexel - Laboratory ...
... Cardax, Inc. (OTCQB:CDXI) announced today that it has entered into a mutual exclusivity ...
... cancer, breast cancer, and prostate cancer. Regen Biopharma, Inc. (OTC: RGBP), Advaxis, Inc. (NASDAQ: ADXS), OncoSec Medical Incorporated (NASDAQ: ONCS), Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), ...
... RA confirms that Xeljanz is the most requested brand and rheumatologists report Pfizer's DTC campaign is the most influential. Another game-changing event potentially on the ...
... Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) ("Marapharm" or the " Company") ...
... company which operates its healthcare business in the U.S. and Canada as EMD Serono, today announced 11 abstracts are scheduled for presentation in oral and ...
... If you want a Stock Review on AGEN, AKBA, ACOR, or ADXS then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... If you want a Stock Review on PFE, SNY, HRTX, or AERI then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... the summit to bring precision health to the forefront of medicine, including: Pfizer, Bio-Rad, Abcam, The Jackson Laboratory, Cell Signaling Technology and MassBio. The summit, ...
... its NFC Solution with craft beer brewers Oskar Blues and Amplified Ale Works.GSK field trial - This month, Thinfilm announced a field trial with GlaxoSmithKline ...
... endowment fund created at the end of 2016 by the biopharmaceutical company GENFIT with the objective to conduct - together with other key stakeholders committed ...
... PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted ...
... response, offering an additional treatment option to appropriate patients. Bristol-Myers Squibb & Immuno-Oncology: Advancing Oncology ResearchAt Bristol-Myers Squibb, patients are at the center of everything ...
... TheMedicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, October 25, 2017, at ...
... Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the results ...
... Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSXV: ATE, OTCQB: ATBPF) will be attending ...
... and profiles of leading companies in the antibody drug industry, such as AbbVie Inc., Amgen Inc., Biogen Inc., Johnson & Johnson Inc., Merck KGaA, Novartis ...
... Regulated Information Diabetic Eye Disease programs progressing EUR53.7 million cash received from Alcon/Novartis in conjunction with regaining the non-US rights to JETREA Company's end Q3 ...
... split ACQUISITIONS AND MERGERS MINIMUM VALUE $100 MILLION Neuroderm Ltd - Mitsubishi Tanabe Pharma Corp (1.1B) Sciclone Pharmaceuticals Inc - Silver Biotech Investment (605M) NEW ...
... IRVING, Texas, Oct. 20, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata" or the "Company") announced that the primary efficacy and ...
... ACHIEVE trial HOPKINTON, Mass., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment ...
... and improved pruritus in most patients, exhibited a favorable overall tolerability profile Albireo to conduct Phase 3 study in children with progressive familial intrahepatic cholestasis ...
... half of 2018 CAMBRIDGE, Mass., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing ...
... CANADIAN DAILY STOCK REPORT CanniMed Therapeutics Inc. (TSX:CMED), Canada's 3rd largest Conglomerates company by market cap, has increased ...
... CANADIAN DAILY STOCK REPORT Concordia International Corp. (TSX:CXR), Canada's 26th largest Biotechnology company by market cap, has plummeted ...
... CANADIAN DAILY STOCK REPORT MedReleaf Corp. (TSX:LEAF), Canada's largest Conglomerates company by market cap, has lifted 30.0c (2.8%) ...
... Issued Capital SECTION 3 PROFILE SECTION 2 PRICE VOLUME DYNAMICS SECTION 1 INTELGENX TECHNOLOGIES BULLISH SIGNALS Technicals: + Compound Annual Growth Rate (CAGR) in USD ...
... Price to Book of 12.1 [4.2]. 17:00 EDT [-1.9%, 8.7%, CAD2,031] Valeant Pharmaceuticals International falls in 4 out of last 5 days Its MCap is ...
... CANADIAN WEEKLY STOCK REPORT Valeant Pharmaceuticals International, Inc. (TSX:VRX), Canada's largest Drug Manufacturers company by market cap, has sunk ...
... CANADIAN WEEKLY STOCK REPORT Essa Pharma Inc. (TSX:EPI) has dropped 1.50c (or 4.1%) in the past week to ...
... CANADIAN WEEKLY STOCK REPORT Knight Therapeutics Inc. (TSX:GUD) has fallen 17.0c (or 1.9%) to close at CAD8.58. The ...
... CANADIAN WEEKLY STOCK REPORT Jamieson Wellness Inc. (TSX:JWEL), Canada's 3rd largest Health Care Providers company by market cap, ...
... CANADIAN DAILY STOCK REPORT RepliCel Life Sciences Inc. (TSXV:RP), Canada's 48th largest Biotechnology company by market cap, has climbed ...
... CANADIAN DAILY STOCK REPORT IntelGenx Technologies Corp. (TSXV:IGX), Canada's 21st largest Biotechnology company by market cap, traded between ...
... CANADIAN DAILY STOCK REPORT iCo Therapeutics Inc. (TSXV:ICO), Canada's 55th largest Biotechnology company by market cap, has soared ...
... CANADIAN DAILY STOCK REPORT Acerus Pharmaceuticals Corporation (TSX:ASP), Canada's 8th largest Drug manufacturers company by market cap, has ...
... In a nationwide shakeup, Merck & Co. plans to cut 1,800 U.S. staffers as it jettisons three of ...
... had on file, and its records date back to 2001. RELATED: Is Pfizer really weighing a BMS buy? Clues from Q1's earnings call say it ...
... Yescarta (axi-cel) six weeks before deadline. The nod put Gilead right behind Novartis, which won the first-ever CAR-T approval back in August, and which happens ...
... Celgene has scrapped a phase 3 trial of inflammatory bowel disease (IBD) drug ...
... Saltigo GmbH, a subsidiary of specialty chemicals company LANXESS, will be exhibiting at ...
... disease recurrence,' said Murdo Gordon, executive vice president and chief commercial officer, Bristol-Myers Squibb. The application is based on data from the ongoing Phase 3 ...
... AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced ...
... WATERTOWN - Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat ...
... LOS ANGELES - CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
... PLYMOUTH MEETING - Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced initiation of a phase 1b/2 immuno-oncology trial to ...
... SAN DIEGO - TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization ...
... in food, beverage, and beauty industries such as Breakthru Beverages, Green Chef, Shiseido Americas, and more. The event’s theme, "The Modern Workplace," will be reflected ...
... Australian Pharmaceutical Industries chief Richard Vincent is the latest retail leader to lash out ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤